What does FRESCI do?
FRESCI helps biomedical companies, research organisations and public institutions turn human-relevant science into evidence, strategy and practical delivery.
FRESCI / answers for real decisions
Explore practical answers about FRESCI’s science, strategy and delivery work for human-relevant biomedicine—from Barcelona and Spain to European and international teams.
Short answers first. Scope, evidence and uncertainty remain explicit.
The shortest answers to the questions people ask before contacting a science and strategy consultancy.
FRESCI helps biomedical companies, research organisations and public institutions turn human-relevant science into evidence, strategy and practical delivery.
FRESCI works with NAM developers, biotech and medtech companies, biomedical platform teams, research organisations, public institutions, funders, consortia and teams building AI or data tools for science.
An engagement starts with the decision, task or deadline. FRESCI then agrees the outputs, inputs, responsible people, timetable, fee and acceptance criteria before delivery begins.
Answers for teams looking for a Barcelona, Spain, European or international partner.
FRESCI is based in Barcelona, Spain, and supports European, EU-funded and international biomedical projects through remote and collaborative delivery.
Yes. FRESCI can support Barcelona- and Spain-based companies, universities, hospitals, public bodies and innovation ecosystems with evidence reviews, project strategy, proposals, digital-health work and delivery support.
Yes. FRESCI supports defined assignments within European research and innovation programmes, including evidence work, proposal development, project management, dissemination strategy and business or regulatory intelligence.
Yes. FRESCI can work with international teams when the assignment, stakeholders, evidence base and delivery arrangements are clearly defined.
Different audiences need different evidence, language and decision routes.
Yes. FRESCI supports biotech and pharmaceutical teams with evidence synthesis, translational strategy, NAM adoption, scientific documents, project delivery and decision-focused reviews.
Yes. FRESCI supports medtech and digital-health projects with market and business questions, evidence and adoption strategy, regulatory-science intelligence, user research and project delivery.
Research organisations can commission evidence synthesis, project strategy, scientific documents, proposal support, knowledge resources, stakeholder communication or defined delivery capacity.
Public institutions and policy teams can work with FRESCI on evidence reviews, policy and regulatory-science intelligence, landscape mapping, workshop outputs, project coordination and public-facing scientific resources.
Investors and funders can use a defined FRESCI review to examine evidence quality, assay fit, comparator logic, technology positioning, adoption questions, project risks and claim boundaries.
Answers for teams evaluating a model, platform, workflow or project.
A NAM evidence review structures the intended use, sources, claims, comparators, limitations and uncertainty around a non-animal or human-relevant model. It helps a team make a clearer adoption, partnership, funding or regulatory-science decision.
FRESCI can help assess evidence, define an assay role, map validation needs and prepare a regulator-aware evidence strategy. A consultancy review does not itself confer regulatory acceptance or replace experimental validation.
Yes. FRESCI can help organoid and organ-on-chip teams define assay fit, benchmark logic, claim limits, reproducibility questions, stakeholder narratives and evidence packages for diligence, funding or regulatory-science discussion.
Yes. FRESCI can assess an AI or data workflow around a defined scientific task, including sources, traceability, review points, failure modes, outputs and delivery requirements.
Yes. A defined commission can cover a biomedical knowledge tool, database or evidence workflow with agreed users, sources, outputs, review arrangements and scope boundaries.
Yes. FRESCI can support proposal development by clarifying the scientific rationale, impact logic, evidence, work packages, partners, risks and delivery plan for the agreed call and scope.
Yes. FRESCI can take on defined project-management responsibilities, including coordination support, work planning, review points, documentation, stakeholder communication and delivery tracking.
Practical questions about starting, scoping and reviewing work.
Yes. An evidence review, market study, proposal, project-management scope, scientific document or defined tool can be commissioned independently.
Timing depends on the question, evidence base, required expertise, readiness of inputs, review work and available capacity. Timing is agreed as part of the scope rather than promised generically.
Fees depend on the defined outputs, inputs, expertise, delivery timetable, review requirements and responsibility arrangement. A fee is agreed before work begins.
Confidentiality, document access, data handling and permitted use should be agreed before confidential material is shared. The appropriate arrangement depends on the assignment and the parties involved.
FRESCI provides scientific, regulatory-science, evidence and strategy support within the agreed scope. Its work does not itself constitute regulatory approval, legal advice or a guarantee of an authority decision.
Email info@fre-sci.com or send a project enquiry on the FRESCI homepage to describe the decision, task or deliverable that needs support.
Have a specific evidence, strategy or delivery question?
Discuss your project ↗